Anthropic bought a one-person, AI-powered biotech: is this drug discovery’s future?

nature.com2 min read

Anthropic's acquisition of the single-person biotechnology startup Mithril Medicine has sparked industry discussions regarding the future of AI-enabled, ultra-lean drug discovery models. Mithril Medicine utilized AI assistants to analyze data and manage administrative workflows while outsourcing lab work to various contract research organizations. Experts note that while AI empowers smaller teams to move quickly, developing drugs still requires human scientists and extensive external collaboration. Open article →

More on this topic